Literature DB >> 16041765

Flavonoids from the leaves of Litsea japonica and their anti-complement activity.

Sun-Young Lee1, Byung-Sun Min, Jung-Hee Kim, Joongku Lee, Tae-Jin Kim, Chan-Soo Kim, Young-Ho Kim, Hyeong-Kyu Lee.   

Abstract

Four flavonoids, epicatechin (1), afzelin (2), quercitrin (3), and tiliroside (4), were isolated from the leaves of Litsea japonica (Thunb.) Jussieu (Lauraceae). The structures of compounds were identified by comparing their chemical and spectral data with those previously reported. The flavonoids (1-4) were tested for their anti-complement activity against classical pathway of complement system. Compounds 2-4 showed inhibitory activity against complement system with IC50 values of 258, 440, and 101 microm, respectively, whereas 1 was inactive. For the evaluation of the structure-activity relationship of 5,7-dihydroxyflavones, myricitrin (5) from Juglans mandshurica also tested for it's anti-complement activity and is inactive in this assay system. Furthermore, compounds 2, 3, and 5 were hydrolyzed with naringinase to give kaempferol (2a), quercetin (3a), and myricetin (5a), and these were also tested for their activity. Of the three aglycones, 2a exhibited anti-complement activity with an IC50 value of 730 microM, while 3a and 5a were inactive. The inhibitory potencies of 2, 2a, 3, 3a, 5, and 5a against complement activity increased in inverse proportion to number of free hydroxyls on B-ring of 5,7-dihydroxyflavone. Of the compounds tested, 4 showed the most potent inhibitory activity against the complement system. (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041765     DOI: 10.1002/ptr.1453

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  6 in total

1.  The anti-tumor effect and biological activities of the extract JMM6 from the stem-barks of the Chinese Juglans mandshurica Maxim on human hepatoma cell line BEL-7402.

Authors:  Yongli Zhang; Yuqiang Cui; Jiayong Zhu; Hongzhi Li; Jianwen Mao; Xiaobao Jin; Xiangsheng Wang; Yifan Du; Jiazheng Lu
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-12-31

2.  Extract of Litsea japonica ameliorates blood-retinal barrier breakdown in db/db mice.

Authors:  Junghyun Kim; Chan-Sik Kim; Ik Soo Lee; Yun Mi Lee; Eunjin Sohn; Kyuhyung Jo; Joo Hwan Kim; Jin Sook Kim
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

3.  Litsea japonica Extract Inhibits Aldose Reductase Activity and Hyperglycemia-Induced Lenticular Sorbitol Accumulation in db/db Mice.

Authors:  Junghyun Kim; Chan-Sik Kim; Eunjin Sohn; Yun Mi Lee; Kyuhyung Jo; Jin Sook Kim
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-23       Impact factor: 2.629

4.  Litsea japonica extract inhibits neuronal apoptosis and the accumulation of advanced glycation end products in the diabetic mouse retina.

Authors:  Junghyun Kim; Chan-Sik Kim; Yun Mi Lee; Eunjin Sohn; Kyuhyung Jo; Jin Sook Kim
Journal:  Mol Med Rep       Date:  2015-03-24       Impact factor: 2.952

Review 5.  Recent Update on the Role of Chinese Material Medica and Formulations in Diabetic Retinopathy.

Authors:  Sandeep Vasant More; In-Su Kim; Dong-Kug Choi
Journal:  Molecules       Date:  2017-01-04       Impact factor: 4.411

Review 6.  Complement activation and inhibition in wound healing.

Authors:  Gwendolyn Cazander; Gerrolt N Jukema; Peter H Nibbering
Journal:  Clin Dev Immunol       Date:  2012-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.